DOTA-BIM-23014:DOTA-Lanreotide

Product Name: DOTA-BIM-23014:DOTA-Lanreotide
CAS No.: 213187-44-1
Chemical Name: DOTA-BIM-23014:DOTA-Lanreotide
Synonyms: DOTA-Lanreotide;DOTA-Lanreotide acetate;DOTA-BIM-23014:DOTA-Lanreotide;L-Threoninamide, 3-(2-naphthalenyl)-N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-alanyl-Lcysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-Lcysteinyl-,cyclic (2)-disulfide;L-Threoninamide, 3-(2-naphthalenyl)-N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2→7)-disulfide;L-Threoninamide, 3-(2-naphthalenyl)-N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-alanyl-L-cysteinyl-L-Tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2 → 7) disulfide
CBNumber: CB41484182
Molecular Formula: C70H95N15O17S2
Formula Weight: 1482.72
MOL File: 213187-44-1.mol

More

Less

DOTA-BIM-23014:DOTA-Lanreotide Property

Boiling point:: 1750.5±65.0 °C(Predicted)
Density: 1.45±0.1 g/cm3(Predicted)
pka: 1.83±0.10(Predicted)
Sequence: {DOTA}-{d-2Nal}-Cys-Tyr-{d-Trp}-Lys-Val-Cys-Thr (disulfide bridge:Cys2-Cys7)

More

Less

Hazard and Precautionary Statements (GHS)

More

Less

DOTA-BIM-23014:DOTA-Lanreotide Chemical Properties,Usage,Production

Chemical Properties

Colourless to off-white lyophilised powder

Uses

DOTA-Lanreotide is a radionuclide conjugate (RDC), which is capable of binding to a radionuclide. RDC has the ability to specifically target biomolecules and can be used in medical imaging or therapy[1].

DOTA-BIM-23014:DOTA-Lanreotide Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

DOTA-BIM-23014:DOTA-Lanreotide Suppliers

China 2 Germany 1 United States 1 Global 4

Nanchang Tianzhen Biotechnology Co., Ltd

Tel: 13758194781 13173652190
Email: 522013271@qq.com
Country: China
ProdList: 2395
Advantage: 58

Nanjing Typeptide Biotechnology Co.,Ltd.

Tel: 19941518170
Email: sales@typeptide.com
Country: China
ProdList: 3920
Advantage: 58

213187-44-1, DOTA-BIM-23014:DOTA-LanreotideRelated Search:

Lanreotide DOTA

DOTA-BIM-23014:DOTA-Lanreotide

L-Threoninamide, 3-(2-naphthalenyl)-N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-alanyl-L-cysteinyl-L-Tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2 → 7) disulfide

DOTA-Lanreotide

DOTA-Lanreotide acetate

L-Threoninamide, 3-(2-naphthalenyl)-N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-alanyl-Lcysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-Lcysteinyl-,cyclic (2)-disulfide

L-Threoninamide, 3-(2-naphthalenyl)-N-[2-[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-, cyclic (2→7)-disulfide

213187-44-1

C70H95N15O17S2